Please wait a minute...
J Zhejiang Univ (Med Sci)  2018, Vol. 47 Issue (2): 213-217    DOI: 10.3785/j.issn.1008-9292.2018.04.17
    
Focus on pediatric rheumatic and immune diseases
ZHENG Qi(),LU Meiping*()
Department of Rheumatology, Immunology and Allergy, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
Download: HTML( 9 )   PDF(951KB)
Export: BibTeX | EndNote (RIS)      
Key wordsRheumatic diseases      Autoimmune diseases      Macrophage activation syndrome      Autoinflammatory diseases      Type Ⅰ interferonopathy      Child      Biological products      Congresses     
Received: 23 April 2018      Published: 24 July 2018
CLC:  R593.2  
  R725  
Corresponding Authors: LU Meiping     E-mail: zhengqi_chzu@zju.edu.cn;meipinglu@zju.edu.cn
Cite this article:

ZHENG Qi,LU Meiping. Focus on pediatric rheumatic and immune diseases. J Zhejiang Univ (Med Sci), 2018, 47(2): 213-217.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2018.04.17     OR     http://www.zjujournals.com/med/Y2018/V47/I2/213

[1]   RAVELLI A , GROM A A , BEHRENS E M et al. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis:diagnosis, genetics, pathophysiology and treatment[J]. Genes Immun, 2012, 13 (4): 289- 298
doi: 10.1038/gene.2012.3
[2]   MARTINON F , AKSENTIJEVICH I . New players driving inflammation in monogenic autoinflammatory diseases[J]. Nat Rev Rheumatol, 2015, 11 (1): 11- 20
doi: 10.1038/nrrheum.2014.158
[3]   KESSEL C , LIPPITZ K , WEINHAGE T et al. Proinflammatory cytokine environments can drive interleukin-17 overexpression by γ/δ T cells in systemic juvenile idiopathic arthritis[J]. Arthritis Rheumatol, 2017, 69 (7): 1480- 1494
doi: 10.1002/art.v69.7
[4]   崔咏望, 赵明奇, 李丰, 等. 可溶性受体CD163在难治性幼年特发性关节炎(全身型)中的意义及临床分析[J/CD]. 中华临床医师杂志: 电子版, 2013, 7(13): 5857-5860.
CUI Yongwang, ZHAO Mingqi, LI Feng, et al. Significance and clinical analysis of soluble receptor CD163 in intractable systemic onset juvenile idiopathic arthritis[J/CD]. Chinese Journal of Clinicians: Electronic Edition, 2013, 7(13): 5857-5860. (in Chinese)
[5]   SCHULERT G S , CANNA S W . Convergent pathways of the hyperferritinemic syndromes[J]. Int Immunol, 2018, 30 (5): 195- 203
doi: 10.1093/intimm/dxy012
[6]   BEHRENS E M , BEUKELMAN T , PAESSLER M et al. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis[J]. J Rheumatol, 2007, 34 (5): 1133- 1138
[7]   HENTER J I , HORNE A , ARICí M et al. HLH-2004:diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48 (2): 124- 131
doi: 10.1002/(ISSN)1545-5017
[8]   RAVELLI A, MINOIA F, DAVì S, et al. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis[J/OL]. RMD Open, 2016, 2(1): e000161.
[9]   RAVELLI A , MINOIA F , DAVìS et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis:a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative[J]. Arthritis Rheumatol, 2016, 68 (3): 566- 576
doi: 10.1002/art.39332
[10]   噬血细胞综合征中国专家联盟中华医学会儿科学分会血液学组 . 噬血细胞综合征诊治中国专家共识[J]. 中华医学杂志, 2018, 98 (2): 91- 95
Chinese Expert Alliance on Hemophagocytic Syndrome, Hematology Group, Chinese Pediatric Society, Chinese Medical Association . Expert consensus on diagnosis and treatment of hemophagocytic syndrome[J]. National Medical Journal of China, 2018, 98 (2): 91- 95
[11]   YOKOTA S , ITOH Y , MORIO T et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis under treatment with tocilizumab[J]. J Rheumatol, 2015, 42 (4): 712- 722
doi: 10.3899/jrheum.140288
[12]   MIETTUNEN P M , NARENDRAN A , JAYANTHAN A et al. Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy:case series with 12 patients[J]. Rheumatology(Oxford), 2011, 50 (2): 417- 419
doi: 10.1093/rheumatology/keq218
[13]   MOGHADDAS F , ZENG P , ZHANG Y et al. Autoinflammatory mutation in NLRC4 reveals a leucine-rich repeat (LRR)-LRR oligomerization interface[J]. J Allergy Clin Immunol, 2018,
[14]   GVNTHER C , BERNDT N , WOLF C et al. Familial chilblain lupus due to a novel mutation in the exonuclease Ⅲ domain of 3' repair exonuclease 1(TREX1)[J]. JAMA Dermatol, 2015, 151 (4): 426- 431
doi: 10.1001/jamadermatol.2014.3438
[15]   KIM H , SANCHEZ G A , GOLDBACH-MANSKY R . Insights from mendelian interferonopathies:comparison of CANDLE, SAVI with AGS, monogenic lupus[J]. J Mol Med(Berl), 2016, 94 (10): 1111- 1127
[1] KONG Limin,LU Jingyi,ZHU Huajian,ZHANG Jiankang. Research progress on selective immunoproteasome inhibitors[J]. J Zhejiang Univ (Med Sci), 2019, 48(6): 688-694.
[2] LIN Jing,CHEN Zhimin. Research progress on early identification of severe adenovirus pneumonia in children[J]. J Zhejiang Univ (Med Sci), 2019, 48(5): 567-572.
[3] HU Yue, LYU Bin. Development and prospects of fecal microbiota transplantation[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 342-346.
[4] FAN Yihong, LYU Bin. Research frontier of inflammatory bowel disease[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 334-341.
[5] NIU Yubai,ZHANG Lingyan,HAO Zesheng,JI Yuzhu. Relationship between temperament, parenting style and resilience of children aged 3-5 years[J]. J Zhejiang Univ (Med Sci), 2019, 48(1): 75-82.
[6] HUANG Ting,ZHANG Xiaole,LIANG Liang,TAN Zheng,GAO Yue,LI Jianhua,SHU Qiang. Endoscopic lobectomy for 47 children with pulmonary sequestration[J]. J Zhejiang Univ (Med Sci), 2018, 47(3): 272-277.
[7] SONG Chunze,JIANG Guoping,YE Jingjing,HE Jin,YU Jin. Echocardiography in diagnosis of pediatric pulmonary artery sling[J]. J Zhejiang Univ (Med Sci), 2018, 47(3): 250-254.
[8] XU Weize,YE Jingjing,LI Jianhua,ZHANG Zewei,YU Jiangen,SHI Zhuo,YU Jin,SHU Qiang. Efficacy of percutaneous atrial septal defect closure guided by transesophageal echocardiography in children[J]. J Zhejiang Univ (Med Sci), 2018, 47(3): 244-249.
[9] PENG Dandan,ZHOU Xudong. Parents' antibiotic use for children in Ningbo: knowledge, behaviors and influencing factors[J]. J Zhejiang Univ (Med Sci), 2018, 47(2): 156-162.
[10] QI Xiaohua,WANG Xinyi,HE Fan,LIU Biyao,ZHANG Tao,LI Fudong,ZHAI Yujia,LIN Junfen. Risk assessment for emergency events of infectious disease in outlying areas of large-scale activities[J]. J Zhejiang Univ (Med Sci), 2018, 47(2): 124-130.
[11] ZHANG Yuchuan,CHEN Wei. Regulatory effect of Vav1 on T cells and its relation to clinical diseases[J]. J Zhejiang Univ (Med Sci), 2018, 47(1): 75-81.
[12] ZHOU Haijin,XIA Ping,HU Xingyue. A case of neuromyelitis optica spectrum disorders complicated with systemic lupus erythematosus and thymoma[J]. J Zhejiang Univ (Med Sci), 2018, 47(1): 71-74.
[13] LI Yandie, LU Meiping. Progress on the study of NLRP3 inflammasome in autoinflammatory diseases of children[J]. J Zhejiang Univ (Med Sci), 2017, 46(4): 449-453.
[14] WANG Liya, QIAN Yeqing, JIN Fan. Research progress on the safety of offsprings conceived by assisted reproductive technology[J]. J Zhejiang Univ (Med Sci), 2017, 46(3): 279-284.
[15] LU Shen,WANG Qingqing. Focus on the 14th International Symposium on Dendritic Cells[J]. J Zhejiang Univ (Med Sci), 2017, 46(1): 106-109.